Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Business Resources>Business Operations>Labs/Testing

ChromaDex Announces Top Line Results of its Second Human Clinical Trial

TAGS: Healthy Living Ingredients Business Resources
<p>ChromaDex Corp. (NASDAQ:CDXC announced today that the initial results of its second human clinical study of NIAGEN<sup>&reg;</sup> nicotinamide riboside chloride (NR) have confirmed NR significantly and sustainably raises the co-enzyme nicotinamide adenine dinucleotide (NAD+) in 140 healthy human volunteers over 8-weeks.</p>
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
FeatureImage-Alzchem-1540x800-0421.jpg
Paid Content
Creapure® - GRAS certified and Amazon compliant for peace of mind – infographic
Apr 16, 2021
Trojan flag.png
Federal bill introduced to change hemp definition to 1% THC
Apr 01, 2021
U.S. capitol Congress
Congressmen ask Justice, USDA to keep DEA in check over hemp CBD
Apr 01, 2021
As one of North Americarsquos most respected herbalists and botanical researchers Richard ldquoRicrdquo Scalzo has over 25 years of clinical and practical experience with herbal medicines As an innovator and pioneer in the herbal products industry he is a leading authority on the cultivation of herbs extraction processes whole plant standardization and traditional herbal therapies In addition Mr Scalzo is a lifelong student of Vedic philosophy and spiritual practices He regularly teaches he
Patented botanical formulation kills COVID
Mar 12, 2021